ZyVersa Therapeutics enters a $10 million share purchase agreement with Williamsburg Venture Holdings to advance kidney disease treatment development. ZyVersa Therapeutics, Inc. has announced a share ...
WESTON, Fla., June 25, 2025 (GLOBE NEWSWIRE) -- ZyVersa Therapeutics, Inc. (Nasdaq: ZVSA; “ZyVersa”), a clinical stage specialty biopharmaceutical company developing first-in-class drugs for treatment ...
In the past few years, you’ve probably watched with envy as friends and colleagues struck it rich on the latest hot initial public offer (IPO), turning modest investments into crores overnight. It’s ...
DeFi Development Corp. (Nasdaq: DFDV), the first public U.S. company with a treasury strategy focused on accumulating Solana (SOL), has announced a share purchase agreement with RK Capital Management ...
SHENZHEN, July 03, 2025 (GLOBE NEWSWIRE) -- MingZhu Logistics Holdings Limited ("MingZhu" or the "Company") (NASDAQ: YGMZ), an elite provider of logistics and transportation services to businesses, ...
Hosted on MSN
Akari Therapeutics Enters Share Purchase Agreement
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. The latest update is out from Akari ...
Shares of Tonix Pharmaceuticals tumbled after the company said it has entered a sales agreement with Alliance Global Partners, under which AGP may sell up to $150 million shares of Tonix's common ...
Tharimmune enters a securities purchase agreement for 1,188,888 shares of common stock or equivalents at $4.50 per share. The offering is expected to close August 27, 2025, with placement agents ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback